Showing results (11-20 of 91) with videos related to
Sort By:
Pageof 10
Immunologic Research|October 6, 2007
The role of platelet CD154 in the modulation in adaptive immunityDaniel L Sprague, Jennifer M Sowa, Bennett D Elzey, et al.The Journal of Urology|November 17, 2007
Involvement of growth factors in the process of post-vasectomy micro-recanalizationBrandon C Stahl, Timothy L Ratliff, Barry R De Young, et al.Thrombosis Research|November 16, 2010
Platelet CD40L at the interface of adaptive immunityBennett D Elzey, Timothy L Ratliff, Jennifer M Sowa, et al.The Journal of Biological Chemistry|October 10, 2013
Early growth response-1 (EGR-1) and nuclear factor of activated T cells (NFAT) cooperate to mediate CD40L expression in megakaryocytes and plateletsScott A Crist, Bennett D Elzey, Michelle T Ahmann, et al.Journal of Endourology|January 8, 2008
Systemic and cell-specific immune response to laparoscopic and open nephrectomy in porcine modelDavid A Duchene, Brian L Gallagher, Timothy L Ratliff, et al.The Journal of Urology|August 13, 2003
Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer modelD Robert Siemens, Scott Crist, J Christopher Austin, et al.International Journal of Genomics|May 11, 2017
Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer DrugsChristopher M Fulkerson, Deepika Dhawan, Timothy L Ratliff, et al.European Journal of Immunology|February 3, 2011
In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory siteJessica M Haverkamp, Scott A Crist, Bennett D Elzey, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2007
Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonistWilliam L Redmond, Michael J Gough, Bridget Charbonneau, et al.Molecular Cancer Therapeutics|November 3, 2021
Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate CancerElia Farah, Zhuangzhuang Zhang, Sagar M Utturkar, et al.Pageof 10